GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -1.34% | 58.81% | -26.23% | 46.67% | 6.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.34% | 57.98% | 28.36% | 61.00% | -3.55% |
| Operating Income | -36.34% | -57.98% | -28.36% | -61.00% | 3.55% |
| Income Before Tax | -36.50% | -58.22% | -28.53% | -61.42% | 2.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.50% | -58.22% | -28.53% | -61.42% | 2.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.50% | -58.22% | -28.53% | -61.42% | 2.79% |
| EBIT | -36.34% | -57.98% | -28.36% | -61.00% | 3.55% |
| EBITDA | -36.35% | -58.01% | -28.37% | -61.03% | 3.56% |
| EPS Basic | 93.98% | -- | -- | -- | -- |
| Normalized Basic EPS | 88.07% | -- | -- | -- | -- |
| EPS Diluted | 93.98% | -- | -- | -- | -- |
| Normalized Diluted EPS | 88.07% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 1,046.86% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 1,046.86% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |